BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 38537220)

  • 1. Incidental Detection of Synchronous Benign Hepatic and Splenic Hemangiomas on 18 F-PSMA PET/CT.
    Alsaleh MH; Alkhars AS; Albensaad M; Alsharif A
    Clin Nucl Med; 2024 Jun; 49(6):e298-e300. PubMed ID: 38537220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidental Detection of Splenic Hemangioma on 68Ga-PSMA PET/CT.
    Sheng K; Le K; Bui C; Mansberg R
    Clin Nucl Med; 2019 Oct; 44(10):821-823. PubMed ID: 31162264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intense 18 F-PSMA-1007 Uptake of Splenic Hemangioma.
    Jia G; Dong A; Cheng C; Zuo C
    Clin Nucl Med; 2024 Feb; 49(2):e90-e92. PubMed ID: 38048527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. False-Positive 18F-PSMA-1007 and True-Negative 18F-Fluorocholine PET/CT Splenic Hemangioma.
    Panagiotidis E; Paschali A; Xourgia X; Chatzipavlidou V
    Clin Nucl Med; 2020 Dec; 45(12):960-961. PubMed ID: 33065626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate-Specific Membrane Antigen PET/CT Findings for Hepatic Hemangioma.
    Bhardwaj H; Stephens M; Bhatt M; Thomas PA
    Clin Nucl Med; 2016 Dec; 41(12):968-969. PubMed ID: 27749413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemangioma of the Ilium Simulating Bone Metastasis on 18 F-PSMA-1007 PET/CT.
    Dong A; Nian S; Bai Y; Zuo C
    Clin Nucl Med; 2024 Jun; 49(6):e304-e306. PubMed ID: 38377381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Splenic Hemangioma as a Potential Pitfall on PSMA-Targeted 18F-DCFPyL PET/CT.
    Chaussé G; Laufer J; Abikhzer G; Probst S
    Clin Nucl Med; 2019 Mar; 44(3):255-256. PubMed ID: 30589670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Prospective Comparison of
    Anttinen M; Ettala O; Malaspina S; Jambor I; Sandell M; Kajander S; Rinta-Kiikka I; Schildt J; Saukko E; Rautio P; Timonen KL; Matikainen T; Noponen T; Saunavaara J; Löyttyniemi E; Taimen P; Kemppainen J; Dean PB; Blanco Sequeiros R; Aronen HJ; Seppänen M; Boström PJ
    Eur Urol Oncol; 2021 Aug; 4(4):635-644. PubMed ID: 32675047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. False-Positive Uptake in Splenic Hemangioma on 68 Ga-DOTATATE PET/CT.
    Zhu B; Yoon E; Mahajan S; Kranz AO
    Clin Nucl Med; 2023 Jun; 48(6):518-519. PubMed ID: 37075248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidental detection of primary hepatocellular carcinoma on 18F-prostate-specific membrane antigen-1007 positron emission tomography/computed tomography imaging in a patient with prostate cancer: A case report.
    Zhao H; Li Y; Hou S; Dai Y; Lin C; Xu S
    Medicine (Baltimore); 2020 Oct; 99(41):e22486. PubMed ID: 33031282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary Spleen Angiosarcoma With Concomitant Hepatic Hemangiomas on 18F-FDG PET/CT.
    Zheng K; Liu Y; Cui R; Li F
    Clin Nucl Med; 2018 Mar; 43(3):222-223. PubMed ID: 29356748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidental Intrahepatic Hepatocellular Cholangiocarcinoma Detected on 68Ga-PSMA PET/CT.
    Kang C; Jiang JY; Lee ME; Shen L; Mansberg R
    Clin Nucl Med; 2022 Mar; 47(3):e291-e293. PubMed ID: 35020661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. False-Positive Uptake in Splenic Hemangioma on 68Ga-PSMA PET/CT Scan for Late Biochemical Recurrence of Prostate Cancer.
    Brazão ÉS; Ribeiro AMB; Lima ENP; da Costa WH; Zequi SC
    Clin Nucl Med; 2022 Jan; 47(1):e14-e16. PubMed ID: 34034314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synchronous Paraganglioma Masquerading as 68Ga-PSMA PET/CT-Avid Metastasis in Carcinoma Prostate-How Specific Is 68Ga-PSMA PET/CT?
    Tyagi S; Singh SK; Narain TA; Singh H; Kumar R; Vadi SK
    Clin Nucl Med; 2019 Jun; 44(6):e420-e422. PubMed ID: 31021914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective, Multisite, International Comparison of
    Emmett L; Metser U; Bauman G; Hicks RJ; Weickhardt A; Davis ID; Punwani S; Pond G; Chua S; Ho B; Johnston E; Pouliot F; Scott AM
    J Nucl Med; 2019 Jun; 60(6):794-800. PubMed ID: 30442757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early lesion detection with
    Wondergem M; Jansen BHE; van der Zant FM; van der Sluis TM; Knol RJJ; van Kalmthout LWM; Hoekstra OS; van Moorselaar RJA; Oprea-Lager DE; Vis AN
    Eur J Nucl Med Mol Imaging; 2019 Aug; 46(9):1911-1918. PubMed ID: 31230088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-Center Comparison of [
    Mirzaei S; Lipp R; Zandieh S; Leisser A
    Curr Oncol; 2021 Oct; 28(5):4167-4173. PubMed ID: 34677271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated 18 F-AIF-FAPI-04 Uptake in Hepatic Hemangioma.
    Sun Y; Cai X; Wang Z; Sun Y; Cheng J
    Clin Nucl Med; 2024 Jan; 49(1):e25-e27. PubMed ID: 38015630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidental Findings of Coexisting Metastatic Pancreatic Cancer in Patients With Prostate Cancer on 18 F-Prostate-Specific Membrane Antigen PET/CT.
    Lu Y; Li C
    Clin Nucl Med; 2022 Dec; 47(12):1103-1104. PubMed ID: 35835124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.